151 related articles for article (PubMed ID: 31966068)
1. Centromere protein F and Forkhead box M1 correlation with prognosis of non-small cell lung cancer.
Li R; Wang X; Zhao X; Zhang X; Chen H; Ma Y; Liu Y
Oncol Lett; 2020 Feb; 19(2):1368-1374. PubMed ID: 31966068
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.
Wang Y; Wen L; Zhao SH; Ai ZH; Guo JZ; Liu WC
Lung Cancer; 2013 Feb; 79(2):173-9. PubMed ID: 23177020
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma.
Li P; Ma G; Cui Z; Zhang S; Su Q; Cai Z
Oncol Lett; 2023 Dec; 26(6):518. PubMed ID: 37920441
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
[TBL] [Abstract][Full Text] [Related]
7. Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.
Wang X; Chen D; Gao J; Long H; Zha H; Zhang A; Shu C; Zhou L; Yang F; Zhu B; Wu W
Cancer Manag Res; 2018; 10():6971-6984. PubMed ID: 30588102
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
[TBL] [Abstract][Full Text] [Related]
9. CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis.
Chen Y; Zhang Y
Strahlenther Onkol; 2023 Feb; 199(2):169-181. PubMed ID: 35748916
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer.
Sun J; Huang J; Lan J; Zhou K; Gao Y; Song Z; Deng Y; Liu L; Dong Y; Liu X
Cancer Cell Int; 2019; 19():264. PubMed ID: 31632198
[TBL] [Abstract][Full Text] [Related]
11. Forkhead box protein M1 predicts outcome in human osteosarcoma.
Fan CL; Jiang J; Liu HC; Yang D
Int J Clin Exp Med; 2015; 8(9):15563-8. PubMed ID: 26629049
[TBL] [Abstract][Full Text] [Related]
12. CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma.
Li M; Zhao J; Yang R; Cai R; Liu X; Xie J; Shu B; Qi S
Cancer Sci; 2022 Apr; 113(4):1220-1234. PubMed ID: 35189004
[TBL] [Abstract][Full Text] [Related]
13. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
[TBL] [Abstract][Full Text] [Related]
14. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
[No Abstract] [Full Text] [Related]
17. Soy isoflavone genistein inhibits hsa_circ_0031250/miR-873-5p/FOXM1 axis to suppress non-small-cell lung cancer progression.
Yu Y; Xing Y; Zhang Q; Zhang Q; Huang S; Li X; Gao C
IUBMB Life; 2021 Jan; 73(1):92-107. PubMed ID: 33159503
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of forkhead box M1 is associated poor survival in patients with nonsmall cell lung cancer.
Liu B; Su F; Lin R; Teng H; Ju Y
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1121-S1123. PubMed ID: 30539856
[TBL] [Abstract][Full Text] [Related]
19. Integrated pan-cancer analysis of centromere protein F and experimental verification of its role and clinical significance in cholangiocarcinoma.
Cao Z; Zeng L; Wang Z; Wen X; Zhang J
Funct Integr Genomics; 2023 May; 23(2):190. PubMed ID: 37247093
[TBL] [Abstract][Full Text] [Related]
20. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
